TACSTD2 and renal cell carcinoma: Here, we investigated whether methylation of TACSTD2 gene loci in RCC associate with clinical parameters of tumor aggressiveness and recurrence free survival (RFS) of patients and identified hypermethylated TACSTD2 loci as a potential prognosticator for RCC.